
Loading, please wait...

Loading, please wait...

Pyogenic spondylitis and tuberculous spondylitis often present with overlapping clinical features, yet their treatment regimens differ significantly. Consequently, the differentiation of pyogenic and tuberculous spondylitis remains a persistent challenge for clinicians worldwide. A recent study by Chen Z et al. introduces MRI-based Epidural Abscess Signal (EAS) and Vertebral Body Signal (VBS) scores to solve this diagnostic dilemma. These quantitative tools allow for early and accurate identification before microbiological confirmation. Therefore, healthcare providers can initiate appropriate antimicrobial therapy sooner, reducing the risk of inappropriate empirical treatments.
Researchers developed these scores using standard imaging sequences. Specifically, the EAS score utilizes signal intensity from T2-weighted imaging, while the VBS score focuses on T1-weighted imaging data. In the study, patients with pyogenic infections consistently demonstrated higher EAS scores and lower VBS scores. Conversely, those with tuberculous spondylitis exhibited higher VBS scores. Furthermore, the combined use of these parameters yielded an area under the curve (AUC) of up to 0.963 in validation cohorts. This high diagnostic performance suggests that these tools are robust and reliable for routine clinical use.
Implementing these MRI-based scores facilitates the differentiation of pyogenic and tuberculous spondylitis at the bedside. Moreover, the study established optimal cutoff values to guide empirical antibiotic choices. By using these quantitative signals, surgeons and radiologists can reduce the delay in targeted treatment. Additionally, these findings emphasize the value of signal intensity ratios as objective biomarkers in spinal imaging. As a result, the integration of EAS and VBS scores into clinical workflows may improve patient outcomes by ensuring the right therapy starts early.
EAS stands for Epidural Abscess Signal, and VBS stands for Vertebral Body Signal. These are MRI-based quantitative tools that measure signal intensities on T2 and T1 weighted images to help differentiate between pyogenic and tuberculous infections.
By providing an early, high-accuracy diagnosis before culture results are available, these scores guide clinicians toward either anti-tuberculous drugs or standard antibiotics, preventing the use of inappropriate empirical therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional clinical judgment. Always seek the advice of a qualified healthcare provider for any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Chen Z et al. Epidural abscess signal (EAS) and vertebral body signal (VBS) scores: MRI-based quantitative tools for early differentiation of pyogenic and tuberculous spondylitis to reduce inappropriate empirical therapy. J Orthop Surg Res. 2026 Mar 08. doi: 10.1186/s13018-026-06786-4. PMID: 41795116.
Yueniwati Y, Christina E. The challenges in differentiating tuberculous from pyogenic spondylitis using magnetic resonance imaging. Reports in Medical Imaging. 2017;10:37-43.
Sadineni RT, et al. A Novel Magnetic Resonance Imaging Scoring System in Making Specific Diagnosis of Tubercular Spondylitis in Advanced Infection. Indian J Musculoskelet Radiol. 2019;1(1):7-13.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


MRI-based EAS and VBS scores offer high accuracy in differentiating pyogenic and tuberculous spondylitis, helping guide early antibiotic therapy effectively...
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today